Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence
Despite global efforts to control tuberculosis (TB) the estimated number of people who developed TB worldwide increased to an all-time record of more than 10 million in 2015. The goal of the World Health Organization (WHO) to reduce the global incidence of TB to less than 100 cases per million by 20...
Main Authors: | Christoph Lange, Anna M. Mandalakas, Barbara Kalsdorf, Claudia M. Denkinger, Martina Sester |
---|---|
Format: | Article |
Language: | English |
Published: |
Case Western Reserve University
2017-01-01
|
Series: | Pathogens and Immunity |
Subjects: | |
Online Access: | https://paijournal.com/index.php/paijournal/article/view/173 |
Similar Items
-
Evaluation of a new tuberculosis-related interferon gamma release assay for tuberculosis infection diagnosis in Huzhou, eastern China
by: Fuchu Qian, et al.
Published: (2013-01-01) -
Diagnostic value of the interferon-γ release assay for tuberculosis infection in patients with Behçet’s disease
by: Xiuhua Wu, et al.
Published: (2019-04-01) -
Characteristics Associated with Negative Interferon-γ Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013–2015
by: Duc T. Nguyen, et al.
Published: (2018-03-01) -
Diagnostic value of ex vivo pleural fluid interferon-gamma versus adapted whole-blood quantiferon-TB gold in tube assays in tuberculous pleural effusion
by: Eman N Eldin, et al.
Published: (2012-01-01) -
Tuberculosis in children: new forms of diagnosis
by: Marina Pinheiro, et al.
Published: (2015-12-01)